Syngene International's consolidated net profit rose 18% in the third quarter of the current financial year, missing analysts ...

Dr. Reddy's Laboratories Ltd.'s profit rose 2% in the third quarter of the current financial year, but missed analysts' ...

Zee Entertainment Enterprises Ltd. has counter claimed $8.06 million plus interest from Star India Pvt. Ltd. in a broadcasting rights dispute for International Cricket Council’s men’s tournaments over ...

Revlimid is a medicine used to treat certain cancers and serious conditions affecting blood cells and bone marrow.

Brokerages have reacted to the third-quarter financial results of UltraTech Cement Ltd., Dr. Reddy's Ltd. and Hindustan Petroleum Corporation Ltd. UltraTech remains a strong pick due to its solid ...

The GIFT Nifty, an early indicator of the Nifty 50’s performance in India, was up 16 or 0.07% at 23,309.5 as of 7:50 a.m.

Japan’s central bank came under fire for its communication when its July rate hike helped set off a historic plunge in the country’s stocks and fueled global market turmoil. This time around, Governor ...

Syngene International revised its revenue expectations due to further delays in the US biotech funding environment during the third quarter.

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Ueda and his fellow board members lifted the overnight call rate by a quarter-percentage point to 0.5% at the end of a two-day meeting.

The price of gold with 99.5% purity rose to Rs 82,330 per 10 grams.

Rupee strengthened by 18 paise to open at 86.28 against the US Dollar, according to Bloomberg, a day after it had closed at 86.46.